Abstract |
A series of 2,3-heteroarylmaleimides 9 and polyheterocondensed imides 12 were prepared in good yields and short reaction time using a very efficient procedure consisting in the condensation of the corresponding anhydrides and N,N-diethylethylenediamine and microwave heating. The antiproliferative activity of the novel molecules was tested against human tumor cells (NCI-H460 lung carcinoma) and rat aortic smooth muscle cells (SMCs). The IC50 values for the novel molecules ranged from 0.08 to 13.9 microM in SMCs, and from 0.84 to 9 microM in the tumor cell line. The activity profile for compounds 9 and 12 is comparable to that obtained for amonafide in NCI-H460, except for fused imides 12b,i which proved to be about 10-fold more potent. Whereas, in rat SMCs, only the compound 12b was shown to be 10-fold more potent than amonafide. Instead 12c is equipotent to amonafide. These results suggest that the extended pi-system and the kind of heteroatom are essential in the binding with the molecular target.
|
Authors | Nicola Ferri, Egle Maria Beccalli, Alessandro Contini, Alberto Corsini, Manuela Antonino, Tiziano Radice, Graziella Pratesi, Stella Tinelli, Franco Zunino, Maria Luisa Gelmi |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 16
Issue 4
Pg. 1691-701
(Feb 15 2008)
ISSN: 1464-3391 [Electronic] England |
PMID | 18061459
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Imides
- Maleimides
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, pharmacology)
- Aorta
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cells, Cultured
- Humans
- Imides
(chemical synthesis, pharmacology)
- Inhibitory Concentration 50
- Maleimides
(chemical synthesis, pharmacology)
- Muscle, Smooth, Vascular
(cytology, drug effects)
- Rats
- Structure-Activity Relationship
|